Stock Track | Guardant Health Soars 6.22% Intraday on Wave of Analyst Price Target Hikes

Stock Track

Feb 20

Guardant Health Inc. (GH) shares soared 6.22% during intraday trading on Friday, marking a significant upward movement for the healthcare stock.

The surge appears driven by a series of positive analyst actions following the company's latest earnings report. Multiple financial firms raised their price targets for Guardant Health, including BTIG (to $145 from $140), JP Morgan (to $130 from $120), Barclays (to $130 from $120), Leerink Partners (to $180 from $170), Stifel (to $130 from $120), TD Cowen (to $135 from $130), and Canaccord (to $135 from $125).

These bullish revisions come after Guardant Health reported quarterly revenue that rose 39.4% year-over-year to $281.27 million, surpassing analyst expectations of $271.01 million. The strong revenue performance despite an earnings per share miss has fueled optimism about the company's growth trajectory among Wall Street analysts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1154894278"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154894278\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154894278?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 22:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154894278","market":"us","top_or_hot":-1,"title":"Stock Track | Guardant Health Soars 6.22% Intraday on Wave of Analyst Price Target Hikes","media":"Stock Track","content":"<p>Guardant Health Inc. (GH) shares soared 6.22% during intraday trading on Friday, marking a significant upward movement for the healthcare stock.</p><p>The surge appears driven by a series of positive analyst actions following the company's latest earnings report. Multiple financial firms raised their price targets for Guardant Health, including BTIG (to $145 from $140), JP Morgan (to $130 from $120), Barclays (to $130 from $120), Leerink Partners (to $180 from $170), Stifel (to $130 from $120), TD Cowen (to $135 from $130), and Canaccord (to $135 from $125).</p><p>These bullish revisions come after Guardant Health reported quarterly revenue that rose 39.4% year-over-year to $281.27 million, surpassing analyst expectations of $271.01 million. The strong revenue performance despite an earnings per share miss has fueled optimism about the company's growth trajectory among Wall Street analysts.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Guardant Health Soars 6.22% Intraday on Wave of Analyst Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Guardant Health Soars 6.22% Intraday on Wave of Analyst Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 22:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guardant Health Inc. (GH) shares soared 6.22% during intraday trading on Friday, marking a significant upward movement for the healthcare stock.</p><p>The surge appears driven by a series of positive analyst actions following the company's latest earnings report. Multiple financial firms raised their price targets for Guardant Health, including BTIG (to $145 from $140), JP Morgan (to $130 from $120), Barclays (to $130 from $120), Leerink Partners (to $180 from $170), Stifel (to $130 from $120), TD Cowen (to $135 from $130), and Canaccord (to $135 from $125).</p><p>These bullish revisions come after Guardant Health reported quarterly revenue that rose 39.4% year-over-year to $281.27 million, surpassing analyst expectations of $271.01 million. The strong revenue performance despite an earnings per share miss has fueled optimism about the company's growth trajectory among Wall Street analysts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GH","symbol_name":"Guardant Health Inc.","start_time":0,"source_url":"","article_id":"1154894278","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154894278","pubTimestamp":1771598119,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Guardant Health Inc. (GH) shares soared 6.22% during intraday trading on Friday, marking a significant upward movement for the healthcare stock.The surge appears driven by a series of positive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GH":"Guardant Health Inc."},"translate_title":"个股追踪|Guardant Health盘中大涨6.22%分析师目标价上调潮","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GH":1},"content_text":"Guardant Health Inc. (GH) shares soared 6.22% during intraday trading on Friday, marking a significant upward movement for the healthcare stock.The surge appears driven by a series of positive analyst actions following the company's latest earnings report. Multiple financial firms raised their price targets for Guardant Health, including BTIG (to $145 from $140), JP Morgan (to $130 from $120), Barclays (to $130 from $120), Leerink Partners (to $180 from $170), Stifel (to $130 from $120), TD Cowen (to $135 from $130), and Canaccord (to $135 from $125).These bullish revisions come after Guardant Health reported quarterly revenue that rose 39.4% year-over-year to $281.27 million, surpassing analyst expectations of $271.01 million. The strong revenue performance despite an earnings per share miss has fueled optimism about the company's growth trajectory among Wall Street analysts.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}